Effect of antibiotic prophylaxis after flexible cystoscopy to prevent symptomatic urinary tract infection: a randomized controlled trial
Abstract
OBJECTIVES: Symptomatic urinary tract infection (UTI) is a common complication of flexible cystoscopy. Although the European Association of Urology (EAU) and the American Urological Association (AUA) do not recommend routine antibiotic prophylaxis for patients without risk factors, a survey revealed that over 90% of urologists at King Chulalongkorn Memorial Hospital (KCMH) and approximately 60% of Thai urologists routinely prescribe antibiotics for all cystoscopy patients, even those at low risk. This study aimed to examine the necessity of antibiotic prophylaxis following flexible cystoscopy in Thailand. MATERIALS AND METHODS: A singlecenter, parallelgroup, randomized controlled noninferiority trial was conducted between August 2024 and January 2025 at the outpatient cystoscopy unit of KCMH, Bangkok, Thailand. A total of 284 patients without UTI risk factors were enrolled and randomly assigned to receive either cefixime or no antibiotics. UTI symptoms were assessed via telephone on day 7 postprocedure. The primary outcome was the incidence of postcystoscopy UTI symptoms, to assess noninferiority compared to those who received antibiotics. The secondary outcome was the overall prevalence of UTI following flexible cystoscopy at KCMH. RESULTS: Of the 284 enrolled patients, 265 completed the study. UTI symptoms occurred in 3.85% of the antibiotic prophylaxis group was not inferior to 5.93% of the noantibiotic group. 13 patients (4.9%) with UTI symptoms were successfully managed…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 284 participants or records.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.